Blog
RSS FeedPosted by Michael Wonder on 18 Jun 2020
Clinical trial costs to develop a new drug may actually be rather modest — or so one study suggests
18 June 2020 - For years, the pharmaceutical industry has maintained that the costs to develop medicines accounts for rising ...
Posted by Michael Wonder on 10 Jun 2020
Price limits will scare off COVID-19 vaccine makers, Fauci warns
10 June 2020 - More than one vaccine will be needed, Fauci says. ...
Posted by Michael Wonder on 08 Jun 2020
U.K. lab to sidestep pharma industry to sell potential virus vaccine
7 June 2020 - Imperial College aims to develop a vaccine that is cheaper and easier to manufacture and is forming ...
Posted by Michael Wonder on 08 Jun 2020
The quest for a vaccine could restore faith in big pharma
4 June 2020 - The boffins of AstraZeneca are showing the way forward ...
Posted by Michael Wonder on 07 Jun 2020
The University of Queensland, CEPI and CSL partner to advance development and manufacture of COVID-19 vaccine candidate
5 June 2020 - A vaccine is anticipated to be available in 2021 if clinical trials are successful. ...
Posted by Michael Wonder on 04 Jun 2020
Trump Administration selects five coronavirus vaccine candidates as finalists
3 June 2020 - The Trump administration has selected five companies, including Moderna, AstraZeneca and Pfizer, as the most likely ...
Posted by Michael Wonder on 03 Jun 2020
The FDA should not rush a COVID-19 vaccine
2 June 2020 - Vaccines are widely expected to offer the best way out of the COVID-19 pandemic. ...
Posted by Michael Wonder on 28 May 2020
Tax payers paid to develop remdesivir but will have no say when Gilead sets the price
27 May 2020 - Critics say government deserves more credit for tens of millions in public money spent to develop coronavirus ...
Posted by Michael Wonder on 28 May 2020
Australia avoids 'risky business' of coronavirus vaccine sweepstakes
27 May 2020 - Australia is avoiding huge financial risks by staying out of the global sweepstakes on coronavirus vaccines. ...
Posted by Michael Wonder on 27 May 2020
Prospective dialogue between developers and regulators makes for better evidence generation
27 May 2020 - EMA, in collaboration with other parties, has recently published two scientific articles outlining the importance of ...
Posted by Michael Wonder on 24 May 2020
U.S. is ahead of China in vaccine race, former FDA chief says
24 May 2020 - Data on Chinese vaccines in clinical development “didn’t look overwhelmingly strong,” Scott Gottlieb said. ...
Posted by Michael Wonder on 21 May 2020
Drug innovation is back in fashion
21 May 2020 - Big pharma is no longer the villain. ...
Posted by Michael Wonder on 20 May 2020
Europe falls behind U.S. in funding coronavirus vaccine and securing access
19 May 2020 - U.S. was faster in shouldering drug companies’ costs to develop and manufacture vaccine candidates, putting the bloc ...
Posted by Michael Wonder on 18 May 2020
Australia must work to avoid 'vaccine nationalism', former top bureaucrat warns
18 May 2020 - A former top bureaucrat has warned the international race to develop a vaccine against the novel ...
Posted by Michael Wonder on 18 May 2020
COVID-19 vaccine frontrunners emerge as rollout debate rages
18 May 2020 - Governments and drug makers are weighing how to roll out coronavirus vaccines, including reserving the first ...